This National Institute on Drug Abuse (NIDA) grant supports pilot or feasibility studies for novel or adapted interventions addressing HIV. It focuses on three key areas: HIV prevention for populations where substance use is a contributing factor, improving HIV care for those with prevalent substance use (including integrated treatment for substance use disorders and HIV), and enhancing the scale, uptake, delivery, or quality of existing, evidence-based HIV prevention or care interventions. The grant considers the full spectrum of substance use, acknowledging its direct and indirect impact on transmission risk. Both primary and secondary prevention efforts are supported, targeting domestic and overseas populations, especially those disproportionately affected by HIV and emergent drug use.
Opportunity ID: 182193
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-12-231 |
| Funding Opportunity Title: | Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation (R34) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 06, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 07, 2015 |
| Current Closing Date for Applications: | May 07, 2015 |
| Archive Date: | Jun 07, 2015 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $225,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education County governments Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments For profit organizations other than small businesses Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This FOA is issued by the National institute on Drug Abuse (NIDA), National Institutes of Health for R34 applications, and provides resources to support (a) pilot or feasibility studies of new or adapted interventions to prevent HIV infection among populations where substance use may be a contributing factor; (b) pilot or feasibility studies of new or adapted interventions to improve the care of HIV infection among populations where substance use is prevalent, including interventions that integrate treatment for substance use disorders and HIV infection; or (c) pilot or feasibility studies to increase the scale, uptake, delivery, and/or quality of HIV prevention or care interventions with established evidence of efficacy. Both primary and secondary prevention will be supported. The full range of substance use will be considered including problematic episodic use and substance use disorders, as well as a full range of substances and modes of administration. The most important consideration is that substance use may affect transmission directly as in the case of injection drug use or may affect transmission risk behavior. Domestic and overseas populations will be considered, with particular attention to populations with disproportionate burden of HIV infection and those where HIV infection and/or drug use are emergent. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-12-231.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.279 | ADOBE-FORMS-B2 | ADOBE-FORMS-B2 | PKG00130890 | Aug 07, 2012 | Sep 24, 2013 | View |
| 93.279 | FORMS-C | Use for due dates after 9/24/2013. | PKG00181215 | Sep 16, 2013 | May 07, 2015 | View |
Package 1
Mandatory forms
182193 RR_SF424_1_2-1.2.pdf
182193 PerformanceSite_1_4-1.4.pdf
182193 RR_OtherProjectInfo_1_3-1.3.pdf
182193 RR_KeyPersonExpanded_1_2-1.2.pdf
182193 PHS398_CoverPageSupplement_1_4-1.4.pdf
182193 PHS398_ResearchPlan_1_3-1.3.pdf
182193 PHS398_Checklist_1_3-1.3.pdf
Optional forms
182193 RR_SubawardBudget30-1.2.pdf
182193 PHS398_ModularBudget_1_2-1.2.pdf
182193 RR_Budget-1.1.pdf
182193 PHS_CoverLetter_1_2-1.2.pdf
Package 2
Mandatory forms
182193 RR_SF424_2_0-2.0.pdf
182193 PHS398_ResearchPlan_2_0-2.0.pdf
182193 PHS398_CoverPageSupplement_2_0-2.0.pdf
182193 RR_KeyPersonExpanded_2_0-2.0.pdf
182193 RR_OtherProjectInfo_1_3-1.3.pdf
182193 PerformanceSite_2_0-2.0.pdf
Optional forms
182193 RR_SubawardBudget30_1_3-1.3.pdf
182193 PlannedReport-1.0.pdf
182193 PHS398_CumulativeInclusionReport-1.0.pdf
182193 PHS398_ModularBudget_1_2-1.2.pdf
182193 RR_Budget_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
